In conclusion, we find that, in PAH, upregulation of MSX1 leads to pulmonary vessel dropout or dedifferentiation by influencing multiple pathway genes associated with vascular development, in a cell-specific manner. Here, MSX1 is linked to pulmonary arterial hypertension.